All posts by: Michael Zand

Gene Therapy Helps Dogs with Muscle Dystrophy – Newsmax

Gene therapy to correct surfactant protein B deficiency in newborns – Medical Xpress

Gene therapy to correct surfactant protein B deficiency in newbornsMedical XpressAn article published in Experimental Biology and Medicine (Volume 242, Issue 13, July, 2017) reports that gene therapy may be used to as an intermediate therapy for newbor… Continue reading

NIH website markets questionable stem cell treatments, then retreats – Genetic Literacy Project

Genetic Literacy ProjectNIH website markets questionable stem cell treatments, then retreatsGenetic Literacy ProjectPotentially dangerous stem cell treatments are being marketed on a website the federal government established to help patients find expe… Continue reading

Synthetic Biology Market Size is Projected to be Around $26 Billion by 2025: Crystal Market Research – PR Newswire UK (press release)

Synthetic Biology Market Size is Projected to be Around $26 Billion by 2025: Crystal Market ResearchPR Newswire UK (press release)A research study titled, Synthetic Biology Market by Product (Oligonucleotide Synthesis, DNA Synthesis, Standardized DNA … Continue reading

Synthetic Biology Market Size is Projected to be Around $26 Billion by 2025: Crystal Market Research – PR Newswire (press release)

Synthetic Biology Market Size is Projected to be Around $26 Billion by 2025: Crystal Market ResearchPR Newswire (press release)A research study titled, Synthetic Biology Market by Product (Oligonucleotide Synthesis, DNA Synthesis, Standardized DNA Part… Continue reading

Fat cells promote blood regeneration – Nature.com

Nature.comFat cells promote blood regenerationNature.comHaematopoietic stem cells (HSCs) reside in the bone marrow, which is a complex microenvironment comprising different cell types that provide the signals that regulate HSC activity. It includes end… Continue reading

Cellectis Granted Patent for CRISPR Use in T-Cells – Pharmaceutical Processing

Pharmaceutical ProcessingCellectis Granted Patent for CRISPR Use in T-CellsPharmaceutical ProcessingEP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1, for the genetic engineering of T-cells. The patent will be issued o… Continue reading